Gateway Investment Advisers LLC Boosts Stock Holdings in Agilent Technologies, Inc. $A

Gateway Investment Advisers LLC boosted its position in Agilent Technologies, Inc. (NYSE:A) by 157.9% during the 2nd quarter, Holdings Channel.com reports. The firm owned 167,191 shares of the medical research company’s stock after purchasing an additional 102,362 shares during the period. Gateway Investment Advisers LLC’s holdings in Agilent Technologies were worth $19,730,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently modified their holdings of the company. Mirae Asset Global Investments Co. Ltd. lifted its stake in shares of Agilent Technologies by 13.5% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 36,674 shares of the medical research company’s stock valued at $4,279,000 after buying an additional 4,362 shares in the last quarter. Assenagon Asset Management S.A. lifted its stake in shares of Agilent Technologies by 8.3% during the 1st quarter. Assenagon Asset Management S.A. now owns 30,827 shares of the medical research company’s stock valued at $3,606,000 after buying an additional 2,371 shares in the last quarter. Alps Advisors Inc. lifted its stake in shares of Agilent Technologies by 29.5% during the 1st quarter. Alps Advisors Inc. now owns 13,358 shares of the medical research company’s stock valued at $1,563,000 after buying an additional 3,040 shares in the last quarter. D.A. Davidson & CO. lifted its stake in shares of Agilent Technologies by 30.4% during the 1st quarter. D.A. Davidson & CO. now owns 9,474 shares of the medical research company’s stock valued at $1,108,000 after buying an additional 2,207 shares in the last quarter. Finally, LGT Capital Partners LTD. lifted its stake in shares of Agilent Technologies by 7.6% during the 1st quarter. LGT Capital Partners LTD. now owns 768,252 shares of the medical research company’s stock valued at $89,870,000 after buying an additional 54,302 shares in the last quarter.

Wall Street Analyst Weigh In

A has been the topic of several recent analyst reports. Evercore ISI lowered their target price on shares of Agilent Technologies from $130.00 to $128.00 and set an “in-line” rating on the stock in a research note on Thursday, August 28th. Robert W. Baird increased their target price on shares of Agilent Technologies from $141.00 to $142.00 and gave the stock an “outperform” rating in a research note on Thursday, August 28th. JPMorgan Chase & Co. lowered their target price on shares of Agilent Technologies from $160.00 to $155.00 and set an “overweight” rating on the stock in a research note on Thursday, May 29th. TD Cowen increased their target price on shares of Agilent Technologies to $150.00 and gave the stock a “buy” rating in a research note on Thursday, May 29th. Finally, Wells Fargo & Company increased their target price on shares of Agilent Technologies from $140.00 to $150.00 and gave the stock an “overweight” rating in a research note on Monday. Six research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $140.08.

Agilent Technologies Price Performance

Shares of NYSE:A opened at $127.18 on Wednesday. The company’s fifty day moving average price is $120.01 and its 200-day moving average price is $115.85. The firm has a market capitalization of $36.06 billion, a price-to-earnings ratio of 29.85, a PEG ratio of 3.91 and a beta of 1.24. Agilent Technologies, Inc. has a one year low of $96.43 and a one year high of $153.84. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.25 and a quick ratio of 1.71.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, hitting analysts’ consensus estimates of $1.37. The firm had revenue of $1.74 billion during the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The business’s quarterly revenue was up 10.1% on a year-over-year basis. During the same period in the previous year, the business posted $1.32 EPS. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. On average, equities research analysts anticipate that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Insider Buying and Selling at Agilent Technologies

In other news, CEO Padraig Mcdonnell sold 1,508 shares of the business’s stock in a transaction that occurred on Tuesday, July 1st. The shares were sold at an average price of $117.44, for a total value of $177,099.52. Following the completion of the sale, the chief executive officer directly owned 37,448 shares in the company, valued at approximately $4,397,893.12. The trade was a 3.87% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.